These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12375635

  • 1. Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.
    Tuthill RJ, Unger JM, Liu PY, Flaherty LE, Sondak VK, Southwest Oncology Group.
    Am J Clin Pathol; 2002 Oct; 118(4):504-11. PubMed ID: 12375635
    [Abstract] [Full Text] [Related]

  • 2. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL, Fine JA, Roush GC, Berwick M.
    Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387
    [Abstract] [Full Text] [Related]

  • 3. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783
    [Abstract] [Full Text] [Related]

  • 4. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E, Mangone L, Lo Scocco G, Carli P.
    Melanoma Res; 2006 Oct 05; 16(5):429-33. PubMed ID: 17013092
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG, Mihm MC, Bufalino R, Zurrida S, Collini P, Cascinelli N.
    Cancer; 1996 Apr 01; 77(7):1303-10. PubMed ID: 8608507
    [Abstract] [Full Text] [Related]

  • 6. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 01; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 7. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
    Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ.
    Ann Surg Oncol; 2004 Apr 01; 11(4):426-33. PubMed ID: 15070604
    [Abstract] [Full Text] [Related]

  • 8. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 01; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 9. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.
    Arch Dermatol; 2009 Oct 01; 145(10):1105-13. PubMed ID: 19841396
    [Abstract] [Full Text] [Related]

  • 10. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y.
    Cancer; 2003 Mar 15; 97(6):1488-98. PubMed ID: 12627514
    [Abstract] [Full Text] [Related]

  • 11. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C.
    Cancer; 2008 Apr 15; 112(8):1795-804. PubMed ID: 18306371
    [Abstract] [Full Text] [Related]

  • 12. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG, Leiter U, Eigentler TK, Garbe C.
    Cancer; 2005 Feb 01; 103(3):616-24. PubMed ID: 15630700
    [Abstract] [Full Text] [Related]

  • 13. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK, Buettner PG, Leiter U, Garbe C, Central Malignant Melanoma Registry of the German Dermatological Society.
    J Clin Oncol; 2004 Nov 01; 22(21):4376-83. PubMed ID: 15514379
    [Abstract] [Full Text] [Related]

  • 14. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS.
    Cancer; 1997 Oct 15; 80(8):1426-31. PubMed ID: 9338466
    [Abstract] [Full Text] [Related]

  • 15. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.
    Ann Surg Oncol; 2006 Dec 15; 13(12):1655-63. PubMed ID: 17016755
    [Abstract] [Full Text] [Related]

  • 16. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A, Young DS, Ghazarian D, Neligan PC.
    Arch Otolaryngol Head Neck Surg; 2007 May 15; 133(5):442-7. PubMed ID: 17515502
    [Abstract] [Full Text] [Related]

  • 17. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.
    J Clin Oncol; 2007 Mar 01; 25(7):869-75. PubMed ID: 17327608
    [Abstract] [Full Text] [Related]

  • 18. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M, Jager PL, Suurmeijer AJ, Plukker JT, van Ginkel RJ, Hoekstra HJ.
    Ned Tijdschr Geneeskd; 2005 Aug 13; 149(33):1845-51. PubMed ID: 16128183
    [Abstract] [Full Text] [Related]

  • 19. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.
    Br J Cancer; 2005 Feb 28; 92(4):662-7. PubMed ID: 15700039
    [Abstract] [Full Text] [Related]

  • 20. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL.
    Ann Surg Oncol; 2007 May 28; 14(5):1604-11. PubMed ID: 17333418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.